This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Niebauer, J. Articles by Yeung, A. C. Search for Related Content PubMed PubMed Citation Articles by Niebauer, J. Articles by Yeung, A. C. Related Collections Cardiovascular Pharmacology Apoptosis Lipid and lipoprotein metabolism Endothelium/vascular type/nitric oxide

(Circulation. 1999;100:1830-1835.)
© 1999 American Heart Association, Inc.

Basic Science Reports

Local L-Arginine Delivery After Balloon Angioplasty Reduces Monocyte Binding and Induces Apoptosis

Josef Niebauer, MD; Severin P. Schwarzacher, MD; Motoya Hayase, MD; Bingyin Wang, MD, PhD; Robert S. Kernoff, RS; John P. Cooke, MD, PhD; Alan C. Yeung, MD

From the Division of Cardiovascular Medicine (J.N., S.P.S., M.H., B.W., R.S.K., J.P.C., A.C.Y.), Stanford University, Stanford, Calif; Division of Cardiology (J.N.), Heart Center, University of Leipzig, Germany; and the Division of Cardiology (S.P.S.), University of Innsbruck, Austria.

Correspondence to Alan C. Yeung, MD, Stanford University School of Medicine, Division of Cardiovascular Medicine, 300 Pasteur Drive, Stanford, CA 94305. E-mail alan_yeung{at}cvmed.stanford.edu

Background—Local administration of L-arginine after balloon angioplasty has been shown to enhance NO generation and inhibit lesion formation. In this study, we assessed the mechanisms by which local delivery of L-arginine inhibits lesion formation.

Methods and Results—New Zealand White rabbits (n=56) were fed a 1% cholesterol diet. After 1 week, both iliac arteries were balloon-denuded, and a local drug delivery catheter was introduced into both iliac arteries to deliver either L-arginine (800 mg/5 mL with and without 100 µCi L-[2,3-³H]-arginine) or saline. Monocyte-endothelial interaction was assessed by functional binding assay; NO activity was measured by chemiluminescence. Intramural administration of radioactively labeled L-arginine led to significantly higher counts in comparison to the contralateral segment for up to 1 week after delivery (676±223 versus 453±93 cpm/mg; P<0.02); this was associated with significantly higher NO levels in the L-arginine–treated segments (394.4±141.6 versus 86.3±34.3 nmol/mg; P<0.01). Even after 2 to 3 weeks, monocyte binding was significantly decreased by treatment with L-arginine as compared with saline infusion (P<0.01). After 4 weeks, there was a 9-fold greater number of apoptotic cells in the vessel wall of L-arginine as compared with the saline-treated segments (P<0.05).

Conclusions—Intramural delivery of L-arginine immediately after angioplasty causes a sustained increase in tissue L-arginine levels associated with enhancement of local NO synthesis. The local increase in NO synthesis is associated with an attenuation of monocyte binding and increased apoptosis of resident macrophages. This treatment strategy could be valuable for the prevention and management of restenosis.

Key Words: atherosclerosis • catheterization • hypercholesterolemia • nitric oxide • restenosis

This article has been cited by other articles:

				J. Dulak, S. P Schwarzacher, R. H Zwick, H. Alber, G. Millonig, C. Weiss, H. Hugel, M. Frick, A. Jozkowicz, O. Pachinger, et al. Effects of local gene transfer of VEGF on neointima formation after balloon injury in hypercholesterolemic rabbits Vascular Medicine, November 1, 2005; 10(4): 285 - 291. [Abstract] [PDF]

				H. L. Gornik and M. A. Creager Arginine and Endothelial and Vascular Health J. Nutr., October 1, 2004; 134(10): 2880S - 2887S. [Abstract] [Full Text] [PDF]

				J. Niebauer, A. J. Maxwell, P. S. Lin, D. Wang, P. S. Tsao, and J. P. Cooke NOS inhibition accelerates atherogenesis: reversal by exercise Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H535 - H540. [Abstract] [Full Text] [PDF]

				D. Tousoulis, C. Antoniades, C. Tentolouris, G. Goumas, C. Stefanadis, and P. Toutouzas L-Arginine in cardiovascular disease: dream or reality? Vascular Medicine, August 1, 2002; 7(3): 203 - 211. [Abstract] [PDF]

				D. Tousoulis, C. Tentolouris, and P. Toutouzas L-Arginine and Thrombosis Circulation, December 18, 2001; 104 (25): e159 - e159. [Full Text] [PDF]

				C. Hay, C. Micko, M. F. Prescott, G. Liau, K. Robinson, and H. De Leon Differential Cell Cycle Progression Patterns of Infiltrating Leukocytes and Resident Cells After Balloon Injury of the Rat Carotid Artery Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1948 - 1954. [Abstract] [Full Text] [PDF]

				G. CONDORELLI, J. K. AYCOCK, G. FRATI, and C. NAPOLI Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice FASEB J, October 1, 2001; 15(12): 2162 - 2170. [Abstract] [Full Text] [PDF]

				C. Napoli, G. Cirino, P. Del Soldato, R. Sorrentino, V. Sica, M. Condorelli, A. Pinto, and L. J. Ignarro Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice PNAS, February 27, 2001; 98(5): 2860 - 2864. [Abstract] [Full Text] [PDF]

				C. Napoli, G. Aldini, J. L. Wallace, F. de Nigris, R. Maffei, P. Abete, D. Bonaduce, G. Condorelli, F. Rengo, V. Sica, et al. Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis PNAS, February 5, 2002; 99(3): 1689 - 1694. [Abstract] [Full Text] [PDF]